Mylan Wins Temporary Injunction Against Apotex for Generic Paxil Sales

Drug Industry Daily
A federal court has granted Mylan’s request for a temporary restraining order to halt all sales of competitor Apotex’s generic version of Paxil CR, the latest step in Mylan’s claim to generic exclusivity on GlaxoSmithKline’s blockbuster antidepressant.

To View This Article:


Subscribe To Drug Industry Daily